Search academic texts

Information × Registration Number 0303U001027, 0102U003049 , R & D reports Title To study antituberculous activity of rifabutin and flurenizid and to work out the effective regimens of chemotherapy with using these drugs in patients with destructive pulmonary tuberculosis popup.stage_title Вивчити бактеріостатичну дію рифабутіну та флуренізиду на різні штами мікобактерій туберкульозу (МБТ). Розробити методику хіміотерапії з включенням рифабутіну або флуренізиду у хворих деструктивним туберкульозом легень, що виділяють . . . Head Byalik Yosyp, Registration Date 10-01-2003 Organization Institute of tuberculosis and pulmonology named by F.G.Yanovsky popup.description2 Bacteriostatic action (BA) of rifabutin (Rb) and flurenizide (Fl) and their clinical efficacy were studied on 39 strains of MBT and 122 patients with destructive lung tuberculosis for development of method their application. It was determined high BA and efficacy these drugs, part cross resistance of MBT among Rb and R and fool among Fl and H, necessity of Rb using every other day. Application sphere - phthisiology. Product Description popup.authors popup.nrat_date 2020-04-02 Close